SCHEMBL10285873

SCHEMBL10285873

Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C)c2cc1N(C)C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.66
KMT2A Q03164 7/20 0.66
MAPT P10636 3/20 0.66
RECQL P46063 3/20 0.66
TDP2 O95551 3/20 0.66
NGF P01138 1/20 0.66
NTRK1 P04629 1/20 0.66
BLM P54132 1/20 0.66
USP2 O75604 4/20 0.48
KDM4E B2RXH2 4/20 0.48
HTT P42858 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
RXFP1 Q9HBX9 2/20 0.48
IDO1 P14902 1/20 0.48
HAT1 O14929 4/20 0.44
RBBP7 Q16576 4/20 0.44
CASP7 P55210 3/20 0.44
CASP1 P29466 2/20 0.44
BRCA1 P38398 2/20 0.44
HSD17B10 Q99714 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lumiflavin SCHEMBL29516802 0.86 MEN1 (0.76) MEN1KMT2AMAPTRECQLTDP2
Lumiflavin SCHEMBL193713 0.86 MEN1 (0.76) MEN1KMT2AMAPTRECQLTDP2
Lumiflavin SCHEMBL6365933 0.85 MEN1 (0.74) MEN1KMT2AMAPTRECQLTDP2
Lumiflavin SCHEMBL6373617 0.84 MEN1 (0.72) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL864869 0.83 MEN1 (0.55) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL864965 0.83 MEN1 (0.58) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL9022677 0.82 MEN1 (0.69) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL864918 0.82 MEN1 (0.69) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL10250507 0.81 MEN1 (0.53) MEN1KMT2AMAPTRECQLTDP2
SCHEMBL865870 0.81 MEN1 (0.56) MEN1KMT2AMAPTRECQLTDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077781-A1 FLAVIN DERIVATIVES GADWOOD ROBERT (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077781-A1 FLAVIN DERIVATIVES BLVRB, FLAD1, FDPS MEN1 4416/4885KMT2A 3259/4885MAPT 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.